Skip to Main Content

Paper Details

FDA-Approved and Emerging Next Generation Predictive Biomarkers for Immune Checkpoint Inhibitors in Cancer Patients.
Front Oncol
95
2021
Author NameAffiliation
Xinmin LiUniversity of California, Los Angeles (university of california los angeles) Technology Center for Genomics & Bioinformatics
  • 1 - 1

Datasets

Release 1.2